SCHEMBL1798779

SCHEMBL1798779

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)N1C[C@@H](C)N(C(c2ccccc2)c2ccccc2)[C@@H](C)C1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SERPINE1 P05121 1/20 0.62
▸ ALDH1A1 P00352 4/20 0.41
▸ GAA P10253 4/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MAPT P10636 6/20 0.40
▸ MAPK1 P28482 3/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ POLB P06746 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ TP53 P04637 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ THRB P10828 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ HTT P42858 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1796908 0.93 SERPINE1 (0.71) SERPINE1ALDH1A1GAASMN1; SMN2CYP1A2
Hydrochloric Acid SCHEMBL1797709 0.92 SERPINE1 (0.70) SERPINE1ALDH1A1GAASMN1; SMN2CYP1A2
SCHEMBL1798810 0.85 SERPINE1 (0.84) SERPINE1CYP3A4
SCHEMBL1796028 0.80 SERPINE1 (0.61) SERPINE1ALDH1A1GAASMN1; SMN2CYP1A2
SCHEMBL1799721 0.78 SERPINE1 (0.75) SERPINE1CYP3A4
SCHEMBL1798978 0.77 SERPINE1 (0.53) SERPINE1ALDH1A1GAASMN1; SMN2CYP1A2
SCHEMBL1796607 0.77 SERPINE1 (0.58) SERPINE1ALDH1A1GAASMN1; SMN2CYP1A2
SCHEMBL1794963 0.77 SERPINE1 (0.52) SERPINE1ALDH1A1GAASMN1; SMN2CYP1A2
SCHEMBL1799657 0.77 SERPINE1 (0.70) SERPINE1ALDH1A1GAASMN1; SMN2CYP1A2
SCHEMBL1798984 0.77 SERPINE1 (1.00) SERPINE1POLBG6PD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 — — US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885ALDH1A1 800/4885GAA 721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback